Although pharmacological inhibition of VEGF-A has proven to be effective in inhibiting angiogenesis and vascular leak associated with cancer and various eye diseases [13], presently, little information is reported on the binding kinetics and affinity of various VEGF inhibitors. This evidence concerns the gene VEGFA and eye disorder.